-
-
G_Fri, Aug 20 - Session 7 - 3rd Annual Conference on Brain Metastases.mp4
Session 7: Imaging Biomarkers Aired on: August 20, 2021 (11:00am - 12:05pm ET) Welcome and Introduction to Day 2 Adrienne Boire Paul Kongkham Rohan Ramakrishna David Shultz Imaging Biomarkers to Guide Patient-Centered Care Caroline Chung Can We Use Imaging to Predict Treatment Outcomes in Mel...
-
G_Sat, Jun 12 - Session 1 - SNO Pediatric Conference.mp4
Education Day Session 1 Aired On: June 12, 2021 (10:00am-12:05pm ET) Health Disparities, Equity, Diversity, and Inclusion in Clinical Trials Sonia Partap Ibrahim Qaddoumi Elysia Alvarez Tabitha Cooney Foundations and Pharma: Forwarding Drug Development Amy Weinstein Michael Cox
-
G_Sat, Oct 2 - Session 3 - First Annual Conference on CNS Clinical Trials
Session 3: Clinical Research Methods in 21st Century and Closing Remarks Aired on: October 2, 2021 (2:05pm – 4:25pm EDT) Precision Oncology Clinical Trial Designs That Integrate Biomarker Evaluation Mei-Yin C. Polley RWE and External Control Arms in CNS Trials Rifaquat Rahman Basket, Umbrella...
-
G_Tue, Dec 7 - Session 3 - Intraoperative Visualization & the Connectome Conference
Session 3: Connectomics Aired on: December 7, 2021 (4:20pm – 5:30pm EST) Connectomics and Precision Medicine: The Future of Tractography and Liquid Biopsy Steven Kalkanis Ian Y. Lee Houtan Noushmehr Tractography for Risk Assessment and Prognostication: Identifying Preoperative Language Tracts...
-
Has adding patient reported outcomes to clinical trials in patients with brain tumor had an impact on patient care? Terri Armstrong
Has adding patient reported outcomes to clinical trials in patients with brain tumor had an impact on patient care? Terri Armstrong
-
Has adding tests of neurocognitive function to clinical trials in patients with brain tumor had an impact on patient care? Jeffrey Wefel
Has adding tests of neurocognitive function to clinical trials in patients with brain tumor had an impact on patient care? Jeffrey Wefel
-
Has adding tests of neurocognitive function to clinical trials in patients with brain tumor had an impact on patient care? Jeffrey Wefel
Has adding tests of neurocognitive function to clinical trials in patients with brain tumor had an impact on patient care? Jeffrey Wefel
-
-
HGG-01_Amanda Saratsis
HGG-01 3D GENOME STRUCTURE IMPACTS GENE EXPRESSION IN PEDIATRIC HIGH-GRADE GLIOMA Contact Presenter Tina Huang1, Juan Wang1, Ye Hou1, Andrea Piunti1, Elizabeth Bartom1, Ali Shilatifard1, Feng Yue1, Amanda Saratsis1,2; 1Northwestern University, Chicago, IL, USA. 2Ann & Robert H. Lurie Chil...
-
HGG-04_Tara Barron
HGG-04 TARGETING GABAERGIC NEURON-GLIOMA SYNAPSES IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) THROUGH ANTI-EPILEPTIC DRUG REPURPOSING Contact Presenter Tara Barron, Vilina Mehta, Pamelyn Woo, Michelle Monje Stanford University, Palo Alto, CA, USA Pediatric high-grade gliomas, including diffuse ...
-
HGG-12_Kasey Skinner
HGG-12 HUMAN IPSC-DERIVED H3.3K27M NEUROSPHERES: A NOVEL MODEL FOR INVESTIGATING DIPG PATHOGENESIS AND DRUG RESPONSE Contact Presenter Kasey Skinner1,2, Tomoyuki Koga3, Shunichiro Miki4,5, Robert F. Gruener6, R. Stephanie Huang7, Frank Furnari4,5, C. Ryan Miller2; 1Neuroscience Curriculum, Un...